Nomura Micro Science Co., Ltd. (TYO:6254)
Japan · Delayed Price · Currency is JPY 3,585.00
-105.00 (-2.85%)
Feb 13, 2026, 3:30 PM JST
Nomura Micro Science Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 103,510 | 96,359 | 73,021 | 49,595 | 31,901 | 30,361 | |
Revenue Growth (YoY) | 89.90% | 31.96% | 47.23% | 55.46% | 5.07% | 44.24% |
Cost of Revenue | 80,986 | 75,249 | 57,614 | 39,223 | 24,245 | 23,235 |
Gross Profit | 22,524 | 21,110 | 15,407 | 10,372 | 7,656 | 7,126 |
Selling, General & Admin | 5,462 | 5,357 | 4,384 | 3,558 | 3,017 | 2,971 |
Research & Development | 381 | 381 | 341 | 256 | 207 | 188 |
Operating Expenses | 5,843 | 5,738 | 4,759 | 3,822 | 3,223 | 3,504 |
Operating Income | 16,681 | 15,372 | 10,648 | 6,550 | 4,433 | 3,622 |
Interest Expense | -2,278 | -1,899 | -589 | -57 | -31 | -32 |
Interest & Investment Income | 116 | 72 | 100 | 45 | 34 | 33 |
Currency Exchange Gain (Loss) | 707 | -260 | 651 | -186 | 106 | -16 |
Other Non Operating Income (Expenses) | 174 | 114 | 9 | 62 | 39 | 29 |
EBT Excluding Unusual Items | 15,400 | 13,399 | 10,819 | 6,414 | 4,581 | 3,636 |
Gain (Loss) on Sale of Investments | 17 | - | - | 1,036 | - | -5 |
Gain (Loss) on Sale of Assets | - | - | 11 | - | - | 1 |
Asset Writedown | - | - | -5 | -1 | - | -24 |
Other Unusual Items | - | - | 2 | - | -4 | 1 |
Pretax Income | 15,417 | 13,399 | 10,827 | 7,449 | 4,577 | 3,609 |
Income Tax Expense | 3,833 | 3,200 | 2,849 | 1,643 | 1,286 | 991 |
Net Income | 11,584 | 10,199 | 7,978 | 5,806 | 3,291 | 2,618 |
Net Income to Common | 11,584 | 10,199 | 7,978 | 5,806 | 3,291 | 2,618 |
Net Income Growth | 193.64% | 27.84% | 37.41% | 76.42% | 25.71% | 105.66% |
Shares Outstanding (Basic) | 38 | 38 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 39 | 39 | 38 | 37 | 37 | 37 |
Shares Change (YoY) | 0.59% | 1.69% | 1.91% | 0.45% | 0.43% | 0.93% |
EPS (Basic) | 306.11 | 270.75 | 213.48 | 156.88 | 89.39 | 71.19 |
EPS (Diluted) | 299.73 | 263.64 | 209.70 | 155.53 | 88.55 | 70.75 |
EPS Growth | 191.97% | 25.72% | 34.83% | 75.64% | 25.15% | 103.76% |
Free Cash Flow | -2,381 | -22,305 | -19,005 | 3,664 | 955 | 5,801 |
Free Cash Flow Per Share | -61.60 | -576.57 | -499.55 | 98.15 | 25.70 | 156.77 |
Dividend Per Share | 80.000 | 80.000 | 62.500 | 37.500 | 21.250 | 13.750 |
Dividend Growth | 18.52% | 28.00% | 66.67% | 76.47% | 54.55% | 66.67% |
Gross Margin | 21.76% | 21.91% | 21.10% | 20.91% | 24.00% | 23.47% |
Operating Margin | 16.11% | 15.95% | 14.58% | 13.21% | 13.90% | 11.93% |
Profit Margin | 11.19% | 10.58% | 10.93% | 11.71% | 10.32% | 8.62% |
Free Cash Flow Margin | -2.30% | -23.15% | -26.03% | 7.39% | 2.99% | 19.11% |
EBITDA | 18,763 | 17,025 | 10,955 | 6,741 | 4,605 | 3,746 |
EBITDA Margin | 18.13% | 17.67% | 15.00% | 13.59% | 14.44% | 12.34% |
D&A For EBITDA | 2,082 | 1,653 | 307 | 191 | 172 | 124 |
EBIT | 16,681 | 15,372 | 10,648 | 6,550 | 4,433 | 3,622 |
EBIT Margin | 16.11% | 15.95% | 14.58% | 13.21% | 13.90% | 11.93% |
Effective Tax Rate | 24.86% | 23.88% | 26.31% | 22.06% | 28.10% | 27.46% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.